arrow
L

Loredana Cifaldi

University of Rome Tor Vergata
H指数:30
被引数:3,219

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer

乳酸介导的NK细胞功能障碍作为乳腺癌的预后标志物和治疗靶点

2026-03-270
OAAI
Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing

校正: ifn-γ 和tnf-α 联合治疗增强了乳腺癌细胞和球体对自然杀伤细胞介导的杀伤的敏感性

2026-01-210
OAAI
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing

联合IFN-γ和TNF-α治疗增强了乳腺癌细胞和球体对自然杀伤细胞介导的杀伤的易感性

2025-10-160
OA
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity

CD64/CD28/CD3ζ嵌合受体重编程T细胞代谢并促进T细胞持久性和免疫功能,同时触发抗体非依赖性和抗体依赖性细胞毒性。

2025-02-170
OA
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
2022-06-256
OAAI